Impact BioMedical Inc. IBO
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -40.53%
- 1 year
- -42.94%
- Open
- 3.52
- Prev close
- 3.87
- Mkt cap
- 32.47M
- Vol
- 15.29K
- Avg vol
- 15.67K
- EPS
- 11.11
- P/E
- 0.34
- Div yield
- 0.00%
More statistics
- Low
- 3.68
- High
- 4.00
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.06
- Inst. own
- 1.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.23
- 200-d avg
- 2.17
- 1y target
- 0.00
6M chart
Events in this range
- Sep 23, 2026Split: 1 for 12.62
Signals (32)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 12, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
Key statistics
- Market cap
- 16.57M
- Enterprise value
- 21.75M
- Trailing P/E
- 14.40
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.53
- EPS (TTM)
- 0.10
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -1.33M
- Total cash
- 2.67M
- Total debt
- 8.01M
- Return on equity
- 3.45%
- Shares outstanding
- 11.50M
- Short % of float
- 0.00%
- 50-day average
- 2.23
- 200-day average
- 2.17
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Impact BioMedical Inc.
Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- impactbiomedinc.com
News
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited)
- CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
- Impact BioMedical Announces 1-For-12.62 Reverse Stock Split, Reducing Shares Outstanding From ~107.8M To ~8.54M, Effective Sept. 23
- Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd.
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
Your note
Sign in to keep a note on IBO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ferguson Wellman Capital Management, Inc. | 0.00% | 36,364 | 52.36K | Sep 29, 2024 |
| HRT Financial LP | 0.00% | 12,502 | 18.00K | Sep 29, 2024 |
| Wells Fargo & Company | 0.00% | 29 | 41 | Sep 29, 2024 |
| Jane Street Group, LLC | 0.00% | 13,361 | 19.24K | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 2,596 | 3.74K | Sep 29, 2024 |
| Barclays Plc | 0.00% | 1,120 | 1.61K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Balanced Index Fund | 0.00% | 154,000 | 221.76K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 0.00% | 5,171,052 | 7.45M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.00% | 26,770 | 38.55K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.00% | 5,820 | 8.38K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.00% | 2,449 | 3.53K | Oct 30, 2024 |